Skip to main content
PLOS One logoLink to PLOS One
. 2022 Dec 21;17(12):e0279289. doi: 10.1371/journal.pone.0279289

HIV incidence and associated risk factors in adolescent girls and young women in South Africa: A population-based cohort study

Lara Lewis 1,*, Ayesha B M Kharsany 1,2, Hilton Humphries 1,3, Brendan Maughan-Brown 4, Sean Beckett 5, Kaymarlin Govender 5, Cherie Cawood 6, David Khanyile 6, Gavin George 5,7
Editor: Hamid Sharifi8
PMCID: PMC9770356  PMID: 36542645

Abstract

Background

In sub-Saharan Africa, high HIV incidence rates in adolescent girls and young women (AGYW) persist despite extensive HIV prevention efforts.

Methods

A prospective cohort of 2,710 HIV-negative AGYW (15–24 years) in KwaZulu-Natal, South Africa were interviewed at baseline and followed-up approximately 18 months later (2014–2017). Associations between HIV seroconversion and socio-demographic and behavioural variables measured at baseline and follow-up were examined using Cox regression and a proximate determinants framework. Inter-relationships between determinants were measured using logistic regression. Separate models were built for 15–19 and 20-24-year-olds.

Results

Weighted HIV incidence was 3.92 per 100 person-years (95% confidence interval: 3.27–4.69; 163 seroconversions over 4,016 person-years). Among 15-19-year-olds, absence of family support (adjusted hazards ratio (aHR): 3.82 (1.89–7.72)), having a circumcised partner (aHR: 0.5 (0.27–0.94)) or one who was HIV-positive and not on antiretroviral therapy (ART) (aHR: 6.21 (2.56–15.06)) were associated with HIV incidence. Those reporting an absence of family support were also more likely to report >1 partner during follow-up (odds ratio (OR): 2.7(1.11–6.57)). Among 20-24-year-olds, failure to complete secondary school (aHR: 1.89 (1.11–3.21)), inconsistent condom use (aHR: 3.01 (1.14–7.96)) and reporting partner(s) who were HIV-positive and not on ART (aHR: 7.75 (3.06–19.66)) were associated with HIV incidence. Failure to complete secondary school among 20-24-year-olds was associated with inconsistent condom use (OR: 1.82 (1.20–2.77)) and reporting an HIV-positive partner not on ART (OR: 3.53(1.59–7.82)) or an uncircumcised partner (OR: 1.39 (1.08–1.82).

Conclusion

Absence of family support and incomplete schooling are associated with risky sexual behaviours and HIV acquisition in AGYW. In addition, partner-level prevention—condom use, medical circumcision, and viral suppression–continue to play an important role in reducing HIV risk in AGYW. These findings support the use of combination HIV prevention programs that consider structural as well as biological and behavioural HIV risk factors in their design.

Introduction

Reducing HIV incidence rates among adolescent girls and young women aged 15–24 years (AGYW) in sub-Saharan Africa (SSA) is a key focus of the UNAIDS Global AIDS Strategy [1]. AGYW bear an inordinate burden of HIV risk; approximately 4,900 AGYW became infected with HIV every week in 2021 [2]. In South Africa, the country with the largest global burden of HIV, approximately a third of all new HIV infections are among AGYW [3]. Recent data suggests that HIV incidence rates in AGYW in this region have declined but the risk of HIV in this sub-group remains substantial [46]. A clear understanding of the socio-demographic, behavioural and biological determinants of HIV incidence in this vulnerable group is therefore critical for the development and success of global HIV prevention programmes.

The period between age 15 and 24 years is one of considerable biological, cognitive and social change for young women [7]. It marks the transition from child to adult, the move from school to employment, the initiation of sexual activity and, for many young women in South Africa, the beginning of motherhood. Previous research has highlighted several socioeconomic, behavioural and biological characteristics of AGYW that contribute to the disproportionately high HIV incidence rates experienced during this time period [8, 9]. Engagement in sexual relationships with men aged 5 or more years older is a key determinant of risk in AGYW, the primary reason being that, due to the aggregating nature of HIV prevalence in adult men, older male partners are more likely to be HIV-positive than younger ones [10, 11]. Previous research has also suggested that age-disparate relationships are associated with engagement in risky sexual behaviours such as inconsistent condom use and transactional sex [12]. AGYW are biologically more susceptible to HIV than young men owing to the comparatively larger surface area of the cervix-vagina mucosa, the longer HIV mucosal exposure time and differences in the mucosal immunology [13, 14]. High prevalence of other sexually transmitted infections (STIs) among AGYW in SSA also predispose them to a higher risk of HIV acquisition [15, 16]. In addition to behavioural and biological determinants, a number of socioeconomic factors have been associated with HIV incidence in AGYW, including but not limited to, incomplete schooling [1721], orphanhood [22], financial insecurity [23] and gender inequalities [24].

While literature identifying possible risk factors for HIV infection in African women is extensive, few studies have had access to large population-based cohorts of AGYW in high-HIV epidemic settings. Most studies have relied on data collected either during cross-sectional surveys or during clinical trials for HIV prevention interventions on women of varying ages, making it difficult to establish causality and generalize results, respectively. Additionally, many studies investigating the determinants of HIV risk in AGYW have been unsuccessful in delineating causal pathways of HIV acquisition and exploring the relationship between socioeconomic and behavioural/biological drivers of HIV risk. In this study, we identify determinants of HIV incidence in a group of AGYW in a hyperendemic setting using data from a large population-based, cohort study and a proximate determinants framework [25] to structure the analyses. To better understand the pathways through which HIV infections may occur, we measured associations between underlying social/demographic factors and behavioural factors that directly affect the likelihood of an individual being exposed and susceptible to HIV.

Materials and methods

Study design and setting

The study was undertaken in KwaZulu-Natal, South Africa, a province with an estimated HIV prevalence of 27% among individuals aged 15–49 [3]. Contraceptive services, HIV testing and treatment, voluntary medical male circumcision and provision of HIV preexposure and postexposure prophylaxis are freely available through primary health care clinics.

We analysed data from the HIV Incidence Provincial Surveillance System (HIPSS) conducted in the uMgungundlovu district of KwaZulu-Natal [26]. HIPSS comprised of two serial cross-sectional household surveys, with two embedded HIV-negative cohorts comprising of a single follow-up visit. The first survey was conducted between June 2014 and June 2015 and the second between June 2015 and June 2016, and the follow-up visits were completed by January 2017 and August 2017 respectively. Fingerprint biometrics were used to confirm the identity of eligible participants for the follow-up visit. Individuals could be included in both surveys and cohorts if selected, however the overlap was minimal [5].

Multistage sampling was used to select the sample. One individual per household was selected at random and enrolled in the survey on condition they were aged between 15 and 49 years and provided peripheral blood samples for laboratory HIV and pregnancy testing. For those enrolled in the first survey, STI testing for Neisseria gonorrhoeae, Chlamydia trachomatis, Trichomonas vaginalis and Mycoplasma genitalium by multiplex PCR and the serological detection of antibodies to syphilis and HSV-2 was also conducted [16]. Individuals were enrolled in the cohorts if they were HIV negative at survey enrolment and aged between 15 and 35 years. HIV testing was also conducted at the follow-up visit. Standardized face-to-face interviews in which participants answered a series of questions relating to their socio-demographic status and behaviour were performed at enrolment and follow-up. Behavioural data collected at follow-up related specifically to sexual behaviour that occurred in the 12 months preceding follow-up. Further details of the study have been previously published [5]. The present study used data collected at enrolment and follow-up on participants aged 15–24 years. Data collected in the two cohorts were combined and analysed as one successive cohort that began in June 2014 and ended in August 2017.

Conceptual approach

A proximate determinants framework was used to structure the analysis [25]. Proximate determinants of HIV are behavioural and biological characteristics (of the individual and partner) that directly affect the likelihood of an individual being exposed and susceptible to HIV, for example condom use or number of sex partners. Underlying determinants are defined as social, economic, and demographic factors that operate through proximate determinants to influence the likelihood of being exposed to HIV, for example, marital status or education. Three sets of analyses were conducted to quantify the association between proximate/underlying determinants and HIV incidence and to quantify the association between proximate and underlying determinants themselves:

  1. The association between proximate determinants and HIV incidence was quantified.

  2. The association between underlying determinants and HIV incidence was measured. This association was first measured without adjusting for proximate determinants. Thereafter, the association between underlying determinants and HIV incidence was measured after adjusting for proximate determinants as well. However, if the proximate determinants acted as mediators between underlying determinants and HIV infection, we expect that a model which already includes proximate determinants would not be influenced by the inclusion of underlying determinants.

  3. Finally, to explore how underlying determinants may influence proximate determinants of HIV incidence, the association between the underlying and proximate determinants was quantified.

Analyses were performed separately for 15-19-year-olds and 20-24-year olds as we hypothesized that the factors affecting young girls who are still of school going age are likely to be different from those affecting women who are out of secondary-school, possibly in tertiary education or seeking employment.

Variables

Outcome measure

The main outcome measure in the study was HIV incidence. As the date of each HIV seroconversion was unknown, it was estimated to be the mid-point between the enrolment date and follow-up visit date.

Underlying and proximate determinants comprised socio-demographic, behavioural and biological factors that were measured in the HIPSS survey and ones that have been determined as influencing HIV incidence in literature [19, 27, 28].

Underlying determinants

All underlying determinants were based on variables measured at enrolment as they were expected to be time invariant or relatively stable over the follow-up period. Variables identified as potential underlying determinants included participant age, secondary school completion, total household income, urban/rural residence, orphan status (defined as being both maternally and paternally orphaned) and report of any family (emotional or financial, in the form of money, food, education or shelter) support in the preceding 12 months. Since the normal school-completion age is approximately 18 years in South Africa, the education variable could only be meaningfully interpreted as a measure of risk in AGYW aged 20–24 years.

Proximate determinants

Proximate determinants included the number of lifetime sexual partners reported at enrolment and the number of partners during follow-up, consistent condom use during follow-up, number of STIs at enrolment, engagement in transactional sex during follow-up, and partner characteristics namely, partner(s) age difference (at least one partner ≥ 5 years older versus not), partner(s) circumcision status (all partners circumcised at the beginning or during relationship, versus not), and partner(s) HIV status (at least one sexual partner HIV-positive and not on ART versus none). Partner characteristics were measured using data on the most recent partner reported at enrolment and partnerships occurring during the 12 months preceding follow-up. The circumcision variable did not differentiate between medical or traditional circumcision however prevalence of traditional circumcision in this area is low [29].

Statistical analysis

The association between identified underlying and proximate determinants and HIV incidence was estimated using Cox proportional hazards models. Since data on orphan status and STI testing data was only collected for one of the two cohorts, orphan and STI status were excluded from the Cox regression although included in descriptive analysis. Univariable regression was first performed followed by multivariable regression. All variables included in the univariable were included in the multivariable regression as all variables were hypothesized to be associated with HIV incidence. The association between the underlying determinants and proximate determinants found to be significantly associated with HIV incidence was measured using logistic regression. Unless otherwise stated, all AGYW, regardless of whether they reported having sex before study enrolment, were included in the analysis. However, models that incorporated sexual behaviour variables that were based on follow-up data excluded, by necessity, AGYW who reported not being sexually active in the 12 months preceding follow-up. In addition, 32 AGYW who reported having had sex at enrolment but reported never having sex at follow-up were excluded from analyses using measures of sexual behaviour. Analyses were conducted in SAS, version 9.4 (SAS Institute Inc). Survey weights, which accounted for the unequal probability of selection of each individual and adjusted for differences in non-response rates across age and gender groups, and a significance level of 0.05 were used in analysis.

Ethical approval

The HIPSS study protocol, informed consent and data collections forms were reviewed and approved by the University of KwaZulu-Natal Biomedical Research Ethics Committee (BF269/13), KwaZulu-Natal Provincial Department of Health (HRKM 08/14) and the Associate Director of Science of the Centre for Global Health (CGH) at the United States Centre for Disease Control and Prevention (CDC) in Atlanta, United States of America (CGH 2014–080).

Written informed consent was obtained from participants 18 years and older and parental/guardian /caregiver consent for participants 15 to <18 years of age and individual assent from participants 15 to <18 years of age for study participation. A separate written informed consent was obtained for long term sample storage for confirmation of any discrepant or uncertain results and for future testing if indicated. Each participant was assigned a unique study participant identification number so that their personal data or laboratory results could not be linked to any personal identifiers such as name.

Results

Of the 3518 AGYW who were HIV-negative at the time of enrolment, 2710 (77.0%) completed a follow-visit with a median follow-up time of 17 [(Interquartile range (IQR) 15–21] months. A total of 163 of the 2710 AGYW seroconverted during follow-up resulting in an incidence rate of 3.92 (95% CI: 3.27–4.69) per 100 person-years, and an incidence rate for AGYW aged 15–19 and 20–24 years of 3.74 (95% CI: 2.87–4.86) and 4.13 (95% CI: 3.20–5.33) per 100 person-years respectively (Table 1).

Table 1. Baseline and follow-up characteristics and HIV incidence in adolescent girls and young women enrolled in the HIPSS cohort.

Participant characteristics %(n) HIV incidence rate (#seroconversions/person-years)
15–19 years 20–24 years Total 15–19 years 20–24 years Total
Overall 100(1403) 100(1307) 100(2710) 3.74(92/2071) 4.13(71/1945) 3.92(163/4016)
Highest education level at enrolment (≥ 20 years)
 Did not complete secondary school n/a 31.8(410) n/a n/a 5.94 (35/602) n/a
 Completed secondary or tertiary schooling n/a 68.2(897) n/a n/a 3.31 (47/1343) n/a
Total household income at enrolment
 R0—R500 pm 8.7(129) 11.2(171) 9.8(300) 2.53(8/209) 2.96(12/278) 2.76(20/487)
 R501—R2,500 pm 44.5(636) 44.1(577) 44.3(1213) 4.72(41/934) 5.09(44/851) 4.89(85/1786)
 R2,501—R6,000 pm 36.4(442) 33.6(373) 35.1(815) 3.69(24/626) 2.22(14/533) 3.04(38/1160)
 greater than R6,000 pm 10.5(137) 11.2(124) 10.8(261) 1.89(6/198) 5.06(7/173) 3.38(13/372)
 Missing 59 62 121
Location of residence at enrolment
 Urban 49.3(864) 47.0(791) 48.3(1655) 3.5(50/1279) 4.23(50/1189) 3.83(100/2468)
 Rural 50.7(539) 53.0(516) 51.7(1055) 3.97(31/791) 4.04(32/756) 4.00(63/1547)
Orphan status at enrolment (<18 years)a
 Either father or mother or both are alive 88.2(346) n/a n/a 2.13(11/479) n/a n/a
 Both mother and father are deceased 11.8(43) n/a n/a 9.23(5/59) n/a n/a
 Missing 25
Family support at enrolment
 Receives emotional/financial support from family 91.9(1270) 86.1(1084) 89.2(2354) 3.17(66/1867) 4.15(66/1594) 3.6(132/3461)
 Receives no emotional/financial support from family 8.1(133) 13.9(223) 10.8(356) 10.4(15/203) 4.02(16/351) 6.46(31/554)
Number of lifetime sexual partners at enrolment
 None 58.8(787) 14.4(167) 38.2(954) 1.77(24/1185) 1.39(5/253) 1.71(29/1439)
 1 partner 25.5(369) 37.6(472) 31.1(841) 4.6(25/537) 4.03(23/711) 4.28(48/1249)
 2–4 partners 14.2(189) 43.2(550) 27.6(739) 7.88(22/265) 4.62(43/795) 5.5(65/1061)
 5 or more partners 1.5(24) 4.9(75) 3.1(99) 11.32(5/32) 4.92(6/108) 6.61(11/141)
 Missing 34 43 77
Number of sexual partners in 12 months preceding follow-upc
 None 45.9(618) 20.3(234) 34(852) 1.84(17/908) 2.90(13/334) 2.13(30/1243)
 1 partner 50.3(728) 75.1(995) 61.8(1723) 5.17(58/1076) 4.12(59/1493) 4.58(117/2569)
 > 1 partner 3.8(57) 4.6(76) 4.2(133) 7.76(6/85) 9.67(10/116) 8.75(16/201)
 Missing 0 2 2
Partner(s) ageb
 At least one partner 5 or more years older 36.2(321) 40.7(465) 41.3(786) 5.97(34/473) 3.29(27/705) 4.37(61/1178)
 No partners reported to be 5 or more years older 63.8(528) 59.3(709) 63.9(1237) 5.45(37/801) 5.08(50/1060) 5.25(87/1862)
 Missing 63 46 109
Partner(s) circumcision statusb
 All sexual partners reported to be circumcised 66.4(517) 55.7(630) 60.2(1147) 3.63(32/770) 4.88(41/931) 4.29(73/1702)
 At least one sexual partner was reported not to be circumcised 33.6(277) 44.3(505) 39.8(782) 7.25(29/407) 3.79(34/760) 5.00(63/1167)
 Missing 118 85 203
Partner(s) HIV statusb
 No sexual partner reported to be HIV positive and not on ART 98.3(832) 97.9(1143) 98.1(1975) 5.09(65/1229) 4.10(70/1710) 4.53(135/2939)
 At least one sexual partner reported to be HIV positive and not on ART 1.7(17) 2.1(31) 1.9(48) 30.39(5/22) 18.44(7/42) 22.77(12/64)
 Missing 63 46 109
Condom usec
 Reported always using condoms during sex 23.2(188) 19.6(205) 21.2(393) 5.61(15/282) 2.02(8/309) 3.73(23/592)
 Reported not always using condom during sex 76.8(593) 80.4(858) 78.8(1451) 5.3(49/873) 5.07(61/1289) 5.17(110/2162)
 Missing 4 8 12
Transactional sexc
 Reported receiving money/gifts for sex 9.6(74) 9.2(106) 9.3(180) 5.86(7/109) 6.14(7/154) 6.01(14/264)
 Reported never receiving money/gifts for sex 90.4(711) 90.8(965) 90.7(1676) 5.29(57/1051) 4.26(62/1457) 4.71(119/2509)
Pregnancy history at enrolment
 Currently or previously pregnant 23.4(354) 64.1(851) 42.3(1205) 5.41(31/509) 4.42(59/1257) 4.71(90/1766)
 Never pregnant 76.6(1042) 35.9(448) 57.7(1490) 3.27(50/1548) 3.68(23/673) 3.39(73/2222)
 Missing 7 8 15
Contraception at enrolment
 Currently on a contraceptive method 27.1(391) 63.7(823) 44.1(1214) 5.98(33/562) 4.48(54/1211) 4.97(87/1773)
 Not currently on a contraceptive method 72.9(1012) 36.3(484) 55.9(1496) 2.93(48/1508) 3.52(28/734) 3.11(76/2242)
Reported use of PrEPc 1.3 (17) 2.1 (28) 1.7 (45) 2.09(1/28) 0(0/50) 0.83(1/78)
STI at enrolmentd
 No STIs detected 62.4 (393) 39.1 (254) 51.8 (647) 2.91(16/626) 2.54(13/405) 2.79(29/1031)
 One STI detected 25.6 (187) 40.7 (257) 32.5 (444) 5.71(20/292) 3.74(15/411) 4.59(35/704)
 More than one STI detected 12.0 (80) 20.1 (128) 15.7 (208) 11.72(15/119) 7.32(13/205) 9.1(28/325)

aOrphan status only available for second cohort of HIPSS.

bPartner data based on data on most recent partner at enrolment and data from partner(s) reported in the 12 months preceding follow-up.

cBased on behavioural data reported for the 12 months preceding cohort follow-up.

dNeisseria gonorrhoeae, Chlamydia trachomatis, Trichomonas vaginalis, Mycoplasma genitalium, syphilis and HSV-2. STI testing was only conducted for participants in the first HIPSS cohort.

HIV incidence rates for various sub-groups of AGYW are reported in Table 1. Among those who reported never having had sex at enrolment, HIV incidence was 1.71 (95% CI: 1.12–2.60) per 100 person-years. Among AGYW below the age of 18, 11.8% reported being orphans, with an estimated incidence rate of 9.23 (95% CI: 3.86–22.17) per 100 person-years. Most AGYW aged 15–19 years (91.9%) indicated receiving emotional, informational and/or financial support from at least one family member in the 12 months leading up to enrolment in the study. Among those that did not receive this support, HIV incidence was 10.40 (95% CI: 5.67–19.09) per 100 person-years compared to 3.17 (95% CI: 2.38–4.21) among those who did. Almost a third of AGYW aged 20-24-year-olds had not yet completed secondary school although their age exceeded the age-norm of secondary schools. Among them, the HIV incidence rate was 5.94 (95% CI: 3.96–8.89) per 100 person-years. Just under 2% (n = 48) of all AGYW reported knowingly having had sex with an individual who was HIV positive and not on ART and of these AGYW, 25% (n = 12) seroconverted during follow-up.

Compared to those with follow-up data, HIV-negative AGYW who were not available for follow-up (n = 808, 23.0%) were more likely to be aged between 20 and 24 (48.2% versus 54.7%) and reside in a rural area (51.7% versus 76.6%). However, the two groups were comparable with respect to education levels, household income, number of lifetime sexual partnerships and STI status at baseline.

Association between proximate determinants and HIV

The results from bivariable and multivariable models predicting the association between proximate determinants and HIV incidence are shown in Table 2. AGYW who did not report having sex in the 12 months preceding follow-up (n = 852) were excluded from the multivariable analysis as they did not have sexual behaviour data. Among AGYW aged 15–19 years, an increase in the number of lifetime partners reported at enrolment was associated with an increase in HIV incidence (adjusted hazard ratio (aHR): 1.15 (95% CI: 1.01–1.31)). Reporting having a circumcised partner was protective against HIV (aHR = 0.5 (95% CI: 0.27–0.94)) and reporting one or more partners who were thought or known to be HIV positive and not on ART was associated with higher HIV risk (aHR = 6.21 (95% CI: 2.56–15.06)). In bivariable models, an increase in the age of the AGYW’s partner was associated with an increase in HIV incidence (HR = 1.06 (95% CI: 1–1.11)). However, this effect was not significant after controlling for other proximate determinants.

Table 2. Association between proximate determinants and HIV incidence in adolescent girls and young women enrolled in the HIPSS cohort.

15-19-year-old women 20-24-year-old women
Proximate determinants HR (95%CI) HR adjusted for all proximate determinants (95%CI)b HR (95%CI) HR adjusted for all proximate determinants (95%CI)b
# Lifetime sexual partners at enrolment 1.26(1.14–1.4)a 1.15(1.01–1.31)a 1.08(0.99–1.19) 0.97(0.86–1.1)
# Sexual partners in 12 months preceding follow-up
 0 vs 1 1.16(0.55–2.46) n/a 1.07(0.51–2.27) n/a
 2 or more vs 1 1.5(0.55–4.11) 1.5(0.5–4.49) 2.39(1.16–4.95)a 2.85(1.36–5.97)a
Age of oldest partnerc 1.06(1–1.11)a 1.03(0.96–1.1) 0.97(0.9–1.05) 0.98(0.92–1.05)
Partner(s) HIV statusc
 At least one partner known to be HIV positive and not on ART vs
 No partner reported to be HIV positive and not on ART
5.91(2.57–13.59)a 6.21(2.56–15.06)a 4.49(1.86–10.84)a 7.75(3.06–19.66)a
Partner(s) circumcision statusc
 All partners reported to be circumcised vs not all partners reported to be circumcised 0.51(0.29–0.9)a 0.5(0.27–0.94)a 1.26(0.72–2.19) 1.54(0.89–2.67)
Condom use in 12 months preceding follow-upb
 Engaged in condomless sex vs did not report condomless sex 0.94(0.47–1.9) 0.98(0.46–2.12) 2.5(1.05–5.93)a 3.01(1.14–7.96)a
Transactional sex in 12 months preceding follow-upb
 Engaged in transactional sex vs did not report transactional sex 1.13(0.43–2.96) 1.24(0.49–3.15) 1.39(0.53–3.68) 1.56(0.6–4.07)

aSignificant at a 5% significance level.

bFor a sample of women who had sex in the 12 months preceding follow-up.

cFor a sample of women with data on the most recent partner at enrolment and/or partnership data in the 12 months preceding follow-up.

Among AGYW aged 20–24 years, those who reported 2 or more partners in the 12 months preceding their follow-up visit were at higher risk of acquiring HIV than those who only reported having 1 partner over that period (aHR: 2.85 (95% CI: 1.36–5.97)). HIV incidence was also higher among those who reported inconsistent condom use (aHR = 3.01 (95% CI: 1.14–7.96)) and having had sex with a partner who was thought or known to be HIV positive and not on ART (aHR = 7.75 (95% CI: 3.06–19.66)).

Association between underlying determinants and HIV

The results from bivariable models and multivariable models (first adjusting for other underlying determinants and subsequently adjusting for other underlying determinants as well as proximate determinants) measuring the association between underlying determinants and HIV incidence are presented in Table 3. In the bivariate model and the model adjusting for other underlying determinants only, AGYW aged 15–19 years who did not receive support in the form of money or information or emotional support from family members in the 12 months preceding enrolment had higher HIV incidence (Ahr = 3.82 (95% CI: 1.89–7.72)). After including proximate determinants in the model, the effect of family support on HIV incidence was no longer statistically significant. Among AGYW aged 20–24 years, failure to complete secondary education was positively associated with HIV incidence after controlling for other underlying determinants (Ahr = 1.89 (95% CI: 1.11–3.21)). However, this association was only weakly significant after additionally adjusting for proximate determinants (Ahr = 1.67 (95% CI: 0.92–3.04)).

Table 3. Association between underlying determinants and HIV incidence in adolescent girls and young women enrolled in the HIPSS cohort.

15-19-year-old women 20-24-year-old women
Underlying determinants HR (95%CI) HR adjusted for all underlying determinants (95%CI) HR adjusted for all underlying & proximate determinants (95%CI) HR (95%CI) HR adjusted for all underlying determinants (95%CI) HR adjusted for all underlying & proximate determinants (95%CI)
Age at enrolment 1.25(1.08–1.46)a 1.24 (1.06–1.45)a 0.94(0.74–1.2) 0.96(0.82–1.13) 0.92 (0.78–1.09) 0.95(0.78–1.17)
Highest education at enrolment (≥ 20)
 Did not complete secondary school vs completed secondary n/a n/a n/a 1.86(1.07–3.24)a 1.89 (1.11–3.21)a 1.67(0.92–3.04)
Location of residence at enrolment
 Urban vs rural 0.85(0.49–1.45) 0.8 (0.48–1.34) 1.14(0.6–2.15) 0.98(0.59–1.64) 1.01 (0.6–1.69) 0.92(0.51–1.65)
Household income at enrolment
 R0 –R500 pm vs >R6000 pm 1.38(0.42–4.54) 0.88 (0.25–3.09) 1.41(0.31–6.43) 0.58(0.2–1.7) 0.55 (0.19–1.59) 0.43(0.1–1.83)
 R501 –R2,500 pm vs >R6000 pm 2.2(0.84–5.75) 2.2 (0.88–5.51) 2.22(0.7–7.08) 0.96(0.37–2.53) 0.89 (0.35–2.26) 1.16(0.34–3.99)
 R2,501 –R6,000 pm vs >R6000 pm 1.77(0.65–4.82) 1.88 (0.71–4.95) 1.23(0.35–4.27) 0.42(0.14–1.25) 0.4 (0.14–1.2) 0.56(0.13–2.32)
Family support at enrolment
 Receives no family financial/emotional support vs receives family support 3.29(1.57–6.89)a 3.82 (1.89–7.72)a 1.97(0.76–5.11) 1(0.55–1.83) 1.11 (0.6–2.06) 1.09(0.53–2.26)

aSignificant at a 5% significance level.

Association between underlying and proximate determinants

Proximate determinants found to be associated with HIV incidence included number of partners during follow-up, partner(s) reported HIV and ART status, partner circumcision status and condom use. The association between underlying determinants found to be associated with HIV acquisition–education and family support–and these proximate determinants are presented in Table 4. In bivariable analyses, AGYW aged 20–24 years who had not completed their secondary education were found to be at greater risk of having an HIV-positive partner not on ART (odds ratio (OR) = 3.53 (95% CI: 1.59–7.82)) and engaging in condomless sex (OR = 1.82 (95% CI: 1.2–2.77)) and were less likely to have circumcised partners (OR = 0.72(95% CI: 0.55–0.93)). Among AGYW aged 15–19 years who had engaged in sex in the 12 months preceding follow-up, those who lacked family support were more likely to have more than 1 sexual partner (OR = 2.7 (95% CI: 1.11–6.57)).

Table 4. Association between underlying and proximate determinants of HIV in adolescent girls and young women enrolled in the HIPSS cohort.

Odds Ratio (95%CI)
Proximate determinants
Underlying determinants # Partners 12 months before follow-up (2 or more vs 1) Partner(s) HIV status (at least one positive and not on ART vs not) Partner(s) circumcision status (all circumcised vs not) Condom use (inconsistent or no condom use vs consistent condom use)
15–19 years Family support
Receives no financial/emotional support from family, vs receives some support from family
2.7(1.11–6.57)a 2.25(0.64–7.88) 1.47(0.91–2.37) 1.88(0.88–3.98)
20–24 years Highest education level (>20 years)
Did not complete secondary school, vs completed secondary/tertiary
1.62(0.92–2.85) 3.53(1.59–7.82)a 0.72(0.55–0.93)a 1.82(1.2–2.77)a

aSignificant at a 5% significance level.

Discussion

This study examined inter-relationships between socio-demographic, behavioural and biological variables and their association with HIV incidence in a large cohort of AGYW in a hyper-endemic area of South Africa. High HIV incidence rates were observed in all sub-groups of AGYW in this area, even in those in their first year after sexual debut. Proximate determinants found to be strongly positively associated with HIV incidence were the number of sexual partners at enrolment and follow-up, engagement in sex with partners who were uncircumcised, inconsistent condom use and having a sexual partner who was HIV positive and not on ART. Two underlying determinants—namely family support and secondary school completion—were found to be protective against HIV acquisition. The existence of family support and secondary school completion were also negatively associated with the probability of condomless sex, having an uncircumcised partner, having an HIV-positive partner not on ART and the number of sexual partners during follow-up, suggesting possible mechanisms through which these underlying determinants influenced HIV risk.

Approximately 1 in 3 AGYW aged 20 to 24 years in this region reported not completing secondary education. Their risk of acquiring HIV during follow-up was 89% higher than those that had completed their secondary education. AGYW with incomplete schooling were also found to be at increased risk of engaging in high-risk sexual behaviours, namely having sex with an HIV positive partner not on ART, having an uncircumcised partner and engaging in condomless sex, suggesting possible mechanisms through which they are exposed to higher risk of HIV. These findings are consistent with previous literature which has shown that increases in school attendance in AGYW is associated with a reduction in risky sexual behaviour [17, 20] and HIV incidence [18, 30]. Additional years of schooling likely provide young women with greater knowledge of HIV transmission and protection, which in turn reduce their willingness to engage in high-risk sexual behaviours. Through its positive impact on employment opportunities, education may also provide women with a higher level of economic independence from their partners, consequently allowing women to be more discerning about their choice of partner and decisions regarding their sexual health.

Among AGYW aged 15 to 19 years, family support emerged as an important protective factor against HIV acquisition. For those who reported having no emotional or financial support from family members in the 12 months preceding enrolment, HIV incidence rates were more than 3-fold higher during follow-up. Similarly, HIV incidence rates of double orphans were more than 4-fold that of those who had at least one parent alive. There are several ways in which family support may reduce adolescents’ likelihood of engaging in risky sexual behaviour and their HIV risk [31]. Communication and education regarding sexuality within families, parental monitoring and accountability to parents, and family support for academic endeavours are some of the aspects of family structures that assist in minimising sexual risk-taking among adolescents. AGYW who lack family support may also look to partnerships as a source of emotional and/or financial support, particularly adolescent young women for whom formal employment is difficult. Young women lacking family support may therefore be less discriminating about their choice of partner(s), and notably AGYW in this cohort who reported lacking family support had more partners during follow-up. These women may arguably also have less power in their relationships owing to an increased dependency on their partner(s). While evidence quantifying the effect of family support on HIV incidence in AGYW is limited, there is a growing body of evidence suggesting that programmes enhancing family support significantly reduce outcomes proximal to HIV infection [32, 33].

Partner characteristics were shown to have a significant impact on the HIV risk of AGYW. HIV incidence was approximately halved for those who exclusively engaged in sex with circumcised partners (AGYW aged 15–19 years) and for those who consistently used a condom during sex (AGYW aged 20–24 years). AGYW who reported having sex with partners who were thought or known to be HIV positive and not on ART (n = 48, 1.9%) had HIV incidence rates 5-fold higher than those that did not. Lastly, partner age was positively associated with HIV incidence among 15–19 year olds in bivariable analysis. This effect became statistically insignificant after controlling for variables capturing behaviours typically associated with age-disparate relationships–inconsistent condom use, engagement in transactional sex and low rates of partner viral suppression—suggesting that the model partially captured the mechanisms through which age-disparate partnerships increase HIV risk in AGYW. These findings highlight the importance of promoting couples HIV testing and counselling, continuing the roll-out of voluntary medical male circumcision programmes and of engaging men in HIV prevention services.

The results from this study suggest that a myriad of factors—structural, behavioural and biological—contribute to the persistently high HIV incidence rates among AGYW in this area. This underscores the need for the design and implementation of combination HIV prevention programs that address this wide spectrum of risks. The DREAMS program, which aims to reduce HIV incidence among AGYW in high-burden settings and to ensure that AGYW live Determined, Resilient, Empowered, AIDS-free, Mentored and Safe lives (“DREAMS”), is currently implemented in 16 countries in SSA and uses an evidence-based multi-sectoral strategy to address the multidimensional vulnerabilities of AGYW in this region [34]. While it is anticipated that the impact of such a complex program may only be seen in the long-term, promising signs of reductions in HIV incidence are already being observed [35].

These results should be interpreted in the context of the study limitations. The analysis was limited to data collected during the HIPSS study between 2014 and 2017 and excluded potential predictors of HIV incidence. In addition, educational achievement–a key covariate used in multivariable models—may be a proxy for other covariates such as personality traits that could not be controlled for in the models. Social desirability bias may have led to the underreporting of risky sexual behaviour. In addition, although most participants were followed up 18 months after enrolment, behavioural questions at follow-up captured sexual behaviour in the preceding 12 months leaving a gap in behavioural data of approximately 6 months. To partially mitigate this, the behavioural variables used in analysis incorporated both baseline and follow-up data. However, any relationships starting and ending in the period immediately after enrolment and approximately 6 months after may have been excluded. Although less than 5% of AGYW reported having more than 2 partners in the 12 months preceding follow-up, most of these women only provided data on 1 of these partners. Missing data can lead to a loss of statistical power or introduce an unexpected selection bias. However, in this study the number of missing responses to questions in the baseline survey and cohort follow-up visit were generally low, and a comparison of characteristics of those lost to follow-up to those who were followed did not suggest that the two groups were inherently different.

Conclusions

This study highlights the endemic levels of HIV incidence among AGYW living in this region. It supports findings from previous literature that showed that retaining AGYW in school and encouraging partner-level prevention through voluntary medical male circumcision, condom use and HIV treatment as prevention, are critical to preventing new infections among AGYW. Additionally, it underscores the importance of family support structures in reducing the likelihood of AGYW engaging in risky sexual behaviour and acquiring HIV. The challenge remains to design and implement community-based HIV prevention programs that effectively address these issues.

Supporting information

S1 File. Sample dataset.

(PDF)

Acknowledgments

We thank all the study participants, study staff, co-investigators from Epicentre, CAPRISA, HEARD, NICD and CDC and district primary health care clinic staff. We thank our collaborating partners: The National Department of Health, Provincial KwaZulu-Natal Department of Health, uMgungundlovu Health District, the uMgungundlovu District AIDS Council, HIV and AIDS / STI / TB (HAST) unit KwaZulu-Natal, local municipal and traditional leaders, and community members for all their support throughout the study.

Data Availability

All relevant data are within the paper and its Supporting information files.

Funding Statement

The HIV Incidence Provincial Surveillance System (HIPSS) is funded by a cooperative agreement (3U2GGH000372) between Epicentre and the Centers for Disease Control and Prevention (CDC). ABMK is supported by a joint South Africa–U.S. Program for Collaborative Biomedical Research, National Institutes of Health grant (R01HD083343), the South African Department of Science and Innovation and the National Research Foundation’s Centre of Excellence in HIV Prevention (Grant 96354). Support was provided to BMB by the National Research Foundation, South Africa, through the Research Career Advancement Fellowship. The content, findings and conclusions in this paper are those of the author(s) and do not necessarily represent the official views of the Centers for Disease Control and Prevention, or any other funder.

References

  • 1.UNAIDS. End inequalities. End AIDS. Global AIDS Strategy 2021–2026. 2021.
  • 2.UNAIDS. Global HIV & AIDS statistics—Fact sheet 2021 [cited 12 September 2022]. https://www.unaids.org/en/resources/fact-sheet.
  • 3.Simbayi L, Zuma K, Zungu N, Moyo S, Marinda E, Jooste S, et al. South African national HIV prevalence, incidence, behaviour and communication survey, 2017: towards achieving the UNAIDS 90-90-90 targets. 2019.
  • 4.Birdthistle I, Tanton C, Tomita A, de Graaf K, Schaffnit SB, Tanser F, et al. Recent levels and trends in HIV incidence rates among adolescent girls and young women in ten high-prevalence African countries: a systematic review and meta-analysis. The Lancet Global Health. 2019;7(11):e1521–e40. doi: 10.1016/S2214-109X(19)30410-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Kharsany ABM, Cawood C, Lewis L, Yende-Zuma N, Khanyile D, Puren A, et al. Trends in HIV Prevention, Treatment, and Incidence in a Hyperendemic Area of KwaZulu-Natal, South Africa. JAMA Netw Open. 2019;2(11):e1914378. doi: 10.1001/jamanetworkopen.2019.14378 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Vandormael A, Akullian A, Siedner M, de Oliveira T, Barnighausen T, Tanser F. Declines in HIV incidence among men and women in a South African population-based cohort. Nat Commun. 2019;10(1):5482. doi: 10.1038/s41467-019-13473-y [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Patton GC, Sawyer SM, Santelli JS, Ross DA, Afifi R, Allen NB, et al. Our future: a Lancet commission on adolescent health and wellbeing. The Lancet. 2016;387(10036):2423–78. doi: 10.1016/S0140-6736(16)00579-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Harrison A, Colvin CJ, Kuo C, Swartz A, Lurie M. Sustained High HIV Incidence in Young Women in Southern Africa: Social, Behavioral, and Structural Factors and Emerging Intervention Approaches. Curr HIV/AIDS Rep. 2015;12(2):207–15. doi: 10.1007/s11904-015-0261-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Dellar RC, Dlamini S, Karim QA. Adolescent girls and young women: key populations for HIV epidemic control. J Int AIDS Soc. 2015;18(2 Suppl 1):19408. doi: 10.7448/IAS.18.2.19408 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.de Oliveira T, Kharsany AB, Graf T, Cawood C, Khanyile D, Grobler A, et al. Transmission networks and risk of HIV infection in KwaZulu-Natal, South Africa: a community-wide phylogenetic study. Lancet HIV. 2017;4(1):e41–e50. doi: 10.1016/S2352-3018(16)30186-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Maughan-Brown B, George G, Beckett S, Evans M, Lewis L, Cawood C, et al. HIV Risk Among Adolescent Girls and Young Women in Age-Disparate Partnerships: Evidence From KwaZulu-Natal, South Africa. J Acquir Immune Defic Syndr. 2018;78(2):155–62. doi: 10.1097/QAI.0000000000001656 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Maughan-Brown B, Evans M, George G. Sexual behaviour of men and women within age-disparate partnerships in South Africa: implications for young women’s HIV risk. PloS one. 2016;11(8):e0159162. doi: 10.1371/journal.pone.0159162 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Jain R, Muralidhar S. Contraceptive methods: needs, options and utilization. J Obstet Gynaecol India. 2011;61(6):626–34. doi: 10.1007/s13224-011-0107-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Yi TJ, Shannon B, Prodger J, McKinnon L, Kaul R. Genital immunology and HIV susceptibility in young women. Am J Reprod Immunol. 2013;69 Suppl 1:74–9. doi: 10.1111/aji.12035 [DOI] [PubMed] [Google Scholar]
  • 15.Cohen MS. HIV and sexually transmitted diseases: lethal synergy. Top HIV Med. 2004;12(4):104–7. [PubMed] [Google Scholar]
  • 16.Kharsany ABM, McKinnon LR, Lewis L, Cawood C, Khanyile D, Maseko DV, et al. Population prevalence of sexually transmitted infections in a high HIV burden district in KwaZulu-Natal, South Africa: Implications for HIV epidemic control. Int J Infect Dis. 2020;98:130–7. doi: 10.1016/j.ijid.2020.06.046 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Stoner MCD, Edwards JK, Miller WC, Aiello AE, Halpern CT, Julien A, et al. Effect of Schooling on Age-Disparate Relationships and Number of Sexual Partners Among Young Women in Rural South Africa Enrolled in HPTN 068. J Acquir Immune Defic Syndr. 2017;76(5):e107–e14. doi: 10.1097/QAI.0000000000001544 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Stoner MCD, Pettifor A, Edwards JK, Aiello AE, Halpern CT, Julien A, et al. The effect of school attendance and school dropout on incident HIV and HSV-2 among young women in rural South Africa enrolled in HPTN 068. AIDS. 2017;31(15):2127–34. doi: 10.1097/QAD.0000000000001584 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Pettifor AE, Levandowski BA, MacPhail C, Padian NS, Cohen MS, Rees HV. Keep them in school: the importance of education as a protective factor against HIV infection among young South African women. Int J Epidemiol. 2008;37(6):1266–73. doi: 10.1093/ije/dyn131 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Hargreaves JR, Morison LA, Kim JC, Bonell CP, Porter JD, Watts C, et al. The association between school attendance, HIV infection and sexual behaviour among young people in rural South Africa. J Epidemiol Community Health. 2008;62(2):113–9. doi: 10.1136/jech.2006.053827 [DOI] [PubMed] [Google Scholar]
  • 21.Hargreaves JR, Bonell CP, Boler T, Boccia D, Birdthistle I, Fletcher A, et al. Systematic review exploring time trends in the association between educational attainment and risk of HIV infection in sub-Saharan Africa. AIDS. 2008;22(3):403–14. doi: 10.1097/QAD.0b013e3282f2aac3 [DOI] [PubMed] [Google Scholar]
  • 22.Operario D, Underhill K, Chuong C, Cluver L. HIV infection and sexual risk behaviour among youth who have experienced orphanhood: systematic review and meta-analysis. Journal of the International AIDS Society. 2011;14(1):1–11. doi: 10.1186/1758-2652-14-25 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Miller CL, Bangsberg DR, Tuller DM, Senkungu J, Kawuma A, Frongillo EA, et al. Food insecurity and sexual risk in an HIV endemic community in Uganda. AIDS Behav. 2011;15(7):1512–9. doi: 10.1007/s10461-010-9693-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Jewkes RK, Dunkle K, Nduna M, Shai N. Intimate partner violence, relationship power inequity, and incidence of HIV infection in young women in South Africa: a cohort study. Lancet. 2010;376(9734):41–8. doi: 10.1016/S0140-6736(10)60548-X [DOI] [PubMed] [Google Scholar]
  • 25.Boerma JT, Weir SS. Integrating demographic and epidemiological approaches to research on HIV/AIDS: the proximate-determinants framework. The Journal of infectious diseases. 2005;191(Supplement_1):S61–S7. doi: 10.1086/425282 [DOI] [PubMed] [Google Scholar]
  • 26.Kharsany AB, Cawood C, Khanyile D, Grobler A, McKinnon LR, Samsunder N, et al. Strengthening HIV surveillance in the antiretroviral therapy era: rationale and design of a longitudinal study to monitor HIV prevalence and incidence in the uMgungundlovu District, KwaZulu-Natal, South Africa. BMC Public Health. 2015;15:1149. doi: 10.1186/s12889-015-2179-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Schaefer R, Gregson S, Eaton JW, Mugurungi O, Rhead R, Takaruza A, et al. Age-disparate relationships and HIV incidence in adolescent girls and young women: evidence from Zimbabwe. AIDS. 2017;31(10):1461–70. doi: 10.1097/QAD.0000000000001506 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Lopman B, Nyamukapa C, Mushati P, Mupambireyi Z, Mason P, Garnett GP, et al. HIV incidence in 3 years of follow-up of a Zimbabwe cohort—1998-2000 to 2001–03: contributions of proximate and underlying determinants to transmission. Int J Epidemiol. 2008;37(1):88–105. doi: 10.1093/ije/dym255 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Davis S, Toledo C, Lewis L, Maughan-Brown B, Ayalew K, Kharsany ABM. Does voluntary medical male circumcision protect against sexually transmitted infections among men and women in real-world scale-up settings? Findings of a household survey in KwaZulu-Natal, South Africa. BMJ Glob Health. 2019;4(3):e001389. doi: 10.1136/bmjgh-2019-001389 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Viner RM, Hargreaves DS, Ward J, Bonell C, Mokdad AH, Patton G. The health benefits of secondary education in adolescents and young adults: an international analysis in 186 low-, middle-and high-income countries from 1990 to 2013. SSM-population health. 2017;3:162–71. doi: 10.1016/j.ssmph.2016.12.004 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Perrino T, Gonzalez-Soldevilla A, Pantin H, Szapocznik J. The role of families in adolescent HIV prevention: a review. Clin Child Fam Psychol Rev. 2000;3(2):81–96. doi: 10.1023/a:1009571518900 [DOI] [PubMed] [Google Scholar]
  • 32.Cluver LD, Orkin FM, Boyes ME, Sherr L. Cash plus care: social protection cumulatively mitigates HIV-risk behaviour among adolescents in South Africa. Aids. 2014;28:S389–S97. doi: 10.1097/QAD.0000000000000340 [DOI] [PubMed] [Google Scholar]
  • 33.Visser M, Zungu N, Ndala-Magoro N. ISIBINDI, creating circles of care for orphans and vulnerable children in South Africa: Post-programme outcomes. AIDS care. 2015;27(8):1014–9. doi: 10.1080/09540121.2015.1018861 [DOI] [PubMed] [Google Scholar]
  • 34.Saul J, Bachman G, Allen S, Toiv NF, Cooney C, Beamon T. The DREAMS core package of interventions: A comprehensive approach to preventing HIV among adolescent girls and young women. PLoS One. 2018;13(12):e0208167. doi: 10.1371/journal.pone.0208167 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Saul J, Cooney C, Hosseini PR, Beamon TA, Toiv N, Bhatt S, et al. Modeling DREAMS impact: trends in new HIV diagnoses among women attending antenatal care clinics in DREAMS countries. AIDS. 2022;36(1):S51–S9. doi: 10.1097/QAD.0000000000003259 [DOI] [PubMed] [Google Scholar]

Decision Letter 0

Hamid Sharifi

1 Aug 2022

PONE-D-22-19202HIV incidence and associated risk factors in adolescent girls and young women in South Africa: A population-based cohort studyPLOS ONE

Dear Mrs. Lara Lewis

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Sep 15 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Hamid Sharifi

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at 

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. You indicated that you had ethical approval for your study. In your Methods section, please ensure you have also stated whether you obtained consent from parents or guardians of the minors included in the study or whether the research ethics committee or IRB specifically waived the need for their consent.

3. In the ethics statement in the Methods and online submission information, please ensure that you have specified (1) whether consent was informed and (2) what type you obtained (for instance, written or verbal, and if verbal, how it was documented and witnessed). If your study included minors, state whether you obtained consent from parents or guardians. If the need for consent was waived by the ethics committee, please include this information.

If you are reporting a retrospective study of medical records or archived samples, please ensure that you have discussed whether all data were fully anonymized before you accessed them and/or whether the IRB or ethics committee waived the requirement for informed consent. If patients provided informed written consent to have data from their medical records used in research, please include this information.

4. We note that you have included the phrase “data not shown” in your manuscript. Unfortunately, this does not meet our data sharing requirements. PLOS does not permit references to inaccessible data. We require that authors provide all relevant data within the paper, Supporting Information files, or in an acceptable, public repository. Please add a citation to support this phrase or upload the data that corresponds with these findings to a stable repository (such as Figshare or Dryad) and provide and URLs, DOIs, or accession numbers that may be used to access these data. Or, if the data are not a core part of the research being presented in your study, we ask that you remove the phrase that refers to these data.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Partly

Reviewer #2: Yes

Reviewer #3: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: I Don't Know

Reviewer #2: Yes

Reviewer #3: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: This is a cohort study aiming to identify determinants of HIV incidence in adolescent girls and young women in a hyperendemic setting in South Africa. It is a very interesting study; however, it presents some gaps, especially in the methodology, and must be improved.

1. I missed the sample size estimation in the Methods section. Is your sample size statistically significant, and the findings of this study can be generalized?

2. The inclusion and exclusion criteria are not clearly stated. They should be presented in the Study design and setting section.

3. An important piece of information not available in the paper is how the two cohorts were linked.

4. How did you analyze the associated factors by statistical or theoretical criteria? In fact, the authors didn’t focus on how this analysis was done in the Statistical analysis section, although this is one of the paper's objectives.

5. Why did you use logistic regression to estimate the association between the underlying and proximate determinants significantly associated with HIV incidence?

6. Role of the Funder/Sponsor: This section can be stated at the end of the paper, after the conclusions.

7. Association between underlying and proximate determinants: This analysis is very confusing! I think a hierarchical analysis model would be better in this context, splitting by underlying and proximate determinants. In this way, the authors could express the analysis in HR instead of OR.

8. Minor issues: It is necessary to add a space between some words and references throughout the text.

Reviewer #2: This is an important study in adolescent and young females at risk of acquiring HIV with a detailed assessment of socioeconomic factors associated.

Few comments:

I would add in the introduction the access of the population studied to preventive tools (testing, attesting, condoms and prep) if that is the case. In the result section I would change the column of baseline characteristics of 15-24 yo to "Total of participants", to make it more clear for readers. The 27% of participants not completing the follow-up, could you provide the characteristics as well in the text? It might be that those have several differences in their social determinants that may have drive them to stop the follow up and I think that is important to address. Regarding the missingness of many variables, I think it would be fair to discuss this more in detail in the discussion section, although it is established as a limitation, I think it deserves more potential explanation to that.

Reviewer #3: Peer Review Template

HIV incidence and associated risk factors in adolescent girls and young women in South Africa: A population-based cohort study

1. Summary of the research

Lewis and colleagues studied socio-demographic, behavioural and biological determinants of HIV incidence among adolescent girls and young women (AGYW) in South Africa. They used a proximate determinants framework to define pathways through which HIV infections could occur in this vulnerable group. The authors concluded that retaining AGYW in school, and having their partners access voluntary medical male circumcision, utilize condoms and be on HIV treatment as prevention all reduce risks of their acquisition of HIV. They also concluded that family support reduces AGYW risky sexual behaviour and HIV acquisition. The authors therefore highlighted the importance of designing and implementing community-based HIV combination prevention programs that effectively address the identified structural, biological and behavioural HIV risk factors in their design.

The research findings are fully consistent with the existing literature and add value to the body of evidence in regard to the causal pathways of HIV acquisition.

The manuscript has a number of strengths. It measures the relationships between both proximate and underlying determinants with HIV incidence and elucidates how underlying determinants influence proximate determinants. It also elucidates causal pathways for the HIV acquisition. Finally, it measures HIV incidence levels in sub-groups of AGYW in this area. One study weakness is that there may be social desirability bias which could have led to underreporting of risky sexual behaviour. The authors however acknowledge this weakness to be taken into account in the interpretation of the study findings.

My overall recommendation is that this is a technically sound manuscript that is well written. It should be accepted with very minor revisions.

2. Examples and evidence

2.1. Major issues

There are no major issues with the manuscript.

2.2. Minor issues

2.2.1. In the introduction, line 62, you could consider specifying to what extent the risk in this sub-group has declined, and to what extent the risk of HIV remains substantial.

2.2.2. In line 65 also in the introduction, you could consider replacing “campaigns” with another word, like “efforts”.

2.2.3. Line 223-225 in the results section refers to AGYW 15-19 years old who received support. The subsequent sentence (line 225-226) gives the incidence among AGYW who did not receive support. Though the incidence among AGYW who received support in included in Table 1, for easier comparison, it could help to include the incidence among those who received support in the text.

2.2.4. For line 229-231 also in the results section, it may be important to report what proportion of AGYW who reported knowingly having sex with individuals who were HIV positive and not on ART did not use protection.

3. Other points (optional)s

None

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

Reviewer #3: Yes: Brian C Chirombo, MPH, MBChB

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2022 Dec 21;17(12):e0279289. doi: 10.1371/journal.pone.0279289.r002

Author response to Decision Letter 0


2 Sep 2022

1. Thank you for the feedback from the PLOS ONE reviewers on our manuscript entitled “HIV incidence and associated risk factors in adolescent girls and young women in South Africa: A population-based cohort study”. We appreciate the opportunity to revise this manuscript. Below we provide a point-by-point response to each of the reviewer comments, with reference to parts of the manuscript that have been updated.

2. Reviewer 1 comments

This is a cohort study aiming to identify determinants of HIV incidence in adolescent girls and young women in a hyperendemic setting in South Africa. It is a very interesting study; however, it presents some gaps, especially in the methodology, and must be improved.

2.1 I missed the sample size estimation in the Methods section. Is your sample size statistically significant, and the findings of this study can be generalized?

Response - Thank you for this observation. We have added a reference to the study protocol in the Methods section as follows: “Further details of the study have been previously published [26, 5].” The HIPSS protocol paper outlines the sample size calculations used in the study. In short, the HIPSS study was powered to detect a difference in the HIV incidence in the two study cohorts. The sample size provided 84 % power to detect a 30 % reduction in HIV incidence rate at a 5 % significance level, given an HIV prevalence of 20 %, loss-to-follow-up of 15 % per annum and an initial HIV incidence rate of 3 per 100 person years. This particular study was based on the results from a sub-analysis of HIPSS data and does not look at the change in incidence but rather predictors of incidence. In total there were 163 HIV seroconversions – a considerably high number given the limited age range of the sample – and these events allowed us to perform an extensive analysis of potential predictors of HIV.

2.2 The inclusion and exclusion criteria are not clearly stated. They should be presented in the Study design and setting section.

Response - Criteria for inclusion into the cohort were based on age, HIV status and willingness to provide blood samples for laboratory testing. Only one person was selected per household and this person was selected at random among the eligible individuals in a household. We have outlined these criteria in the following lines in the Methods section:

“One individual per household was selected at random and enrolled in the survey on condition they were aged between 15 and 49 years and provided peripheral blood samples for laboratory HIV and pregnancy testing.”

“Individuals were enrolled in the cohorts if they were HIV negative at survey enrolment and aged between 15 and 35 years.”

2.3 An important piece of information not available in the paper is how the two cohorts were linked.

Response – Thank you for identifying this important gap. We have amended the Methods section to clarify this by including the following text: “HIPSS comprised of two serial cross-sectional household surveys, with two embedded HIV-negative cohorts comprising of a single follow-up visit. The first survey was conducted between June 2014 and June 2015 and the second between June 2015 and June 2016, and the follow-up visits were completed by January 2017 and August 2017 respectively. Fingerprint biometrics were used to confirm the identity of eligible participants for the follow-up visit. Individuals could be included in both surveys and cohorts if selected, however the overlap was minimal [5].”

2.4 How did you analyze the associated factors by statistical or theoretical criteria? In fact, the authors didn’t focus on how this analysis was done in the Statistical analysis section, although this is one of the paper's objectives.

Response - Factors included in analysis were selected based on their availability in the HIPSS survey and evidence of association in past literature, as stated in the text: “Underlying and proximate determinants comprised socio-demographic, behavioural and biological factors that were measured in the HIPSS survey and ones that have been determined as influencing HIV incidence in literature [20, 27, 28].”

The analysis was structured using a proximate determinants framework as outlined in the section entitled “Conceptual approach”. Cox proportional hazards modelling was then used to model the association between potential risk factors and HIV incidence. We performed a univariable regression followed by a multivariable and we have amended the statistical section to make this clearer: “The association between identified underlying and proximate determinants and HIV incidence was estimated using Cox proportional hazards models. Since data on orphan status and STI testing data was only collected for one of the two cohorts, orphan and STI status were excluded from the Cox regression although included in descriptive analysis. Univariable regression was first performed followed by multivariable regression. All variables included in the univariable were included in the multivariable regression as all variables were hypothesized to be associated with HIV incidence.”

A significance level of 0.05 was used to guide whether associations were considered to be strong or not. The direction of the association – whether it was positive or negative – was determined by whether the hazard ratio was above or below 1.

2.5 Why did you use logistic regression to estimate the association between the underlying and proximate determinants significantly associated with HIV incidence?

Response - The proximate determinants found to be significantly associated with HIV incidence were: number of partners during follow-up (2 or more vs 1), partner(s) reported HIV and ART status (at least one positive and not on ART vs not), partner circumcision status (all circumcised vs not) and condom use (inconsistent or no condom use vs consistent condom use). As these variables are all binary, a logistic regression was the appropriate choice of model for the analysis when analysing the association between these variables and underlying determinants.

2.6 Role of the Funder/Sponsor: This section can be stated at the end of the paper, after the conclusions.

Response - The PLOS ONE's style requirements (found here: https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf ) did not indicate that we could put this section after the conclusions section. We have removed this section as it will be covered in the financial disclosure section if successfully published.

2.7 Association between underlying and proximate determinants: This analysis is very confusing! I think a hierarchical analysis model would be better in this context, splitting by underlying and proximate determinants. In this way, the authors could express the analysis in HR instead of OR.

Response - The association between underlying and proximate determinants and HIV incidence was measured using multivariable Cox regression with results reported in Table 3. This analysis looked at the association between a factor and HIV incidence after adjusting for all other measured factors. Following this analysis, we looked at the association between underlying determinants and proximate determinants as presented in table 4. This analysis was designed to: “explore how underlying determinants may influence proximate determinants of HIV incidence”. We hypothesize- based on the proximate determinants framework - that underlying determinants “operate through proximate determinants to influence the likelihood of being exposed to HIV”. Thus, to test this hypothesis we analyse the association between underlying and proximate determinants with the proximate determinants as the outcome variable. As the proximate determinants variables are binary in nature and have no time element, we cannot use a time-to-event analysis like Cox proportional hazards modelling for this analysis. Logistic regression is a suitable chose for analyses with a binary outcome variable.

2.8 Minor issues: It is necessary to add a space between some words and references throughout the text.

Response - Thank you, this has been addressed.

3. Reviewer 2 comments

This is an important study in adolescent and young females at risk of acquiring HIV with a detailed assessment of socioeconomic factors associated. Few comments:

3.1 I would add in the introduction the access of the population studied to preventive tools (testing, attesting, condoms and prep) if that is the case.

Response - Thank you. We have added this sentence to the Study design and setting section: “Contraceptive services and HIV testing and treatment are freely available through primary health care clinics and, since 2016, oral pre-exposure prophylaxis (PrEP) has been made available to people at substantial risk of HIV infection.” To illustrate that PrEP usage was low in the cohort, we have included frequency of PrEP usage to table 1.

3.2 In the result section I would change the column of baseline characteristics of 15-24 yo to "Total of participants", to make it more clear for readers.

Response - Thank you. We have amended this column to have the heading “Total”.

3.3 The 27% of participants not completing the follow-up, could you provide the characteristics as well in the text? It might be that those have several differences in their social determinants that may have drive them to stop the follow up and I think that is important to address.

Response - Thank you. 23% were not accessible for follow-up. We have added the following text to the results section to provide some insight into this group: “Compared to those with follow-up data, HIV-negative AGYW who were not available for follow-up (n=808, 23.0%) were more likely to be aged between 20 and 24 (48.2% versus 54.7%) and reside in a rural area (51.7% versus 76.6%). However, the two groups were comparable with respect to education levels, household income, number of lifetime sexual partnerships and STI status at baseline.”

3.4 Regarding the missingness of many variables, I think it would be fair to discuss this more in detail in the discussion section, although it is established as a limitation, I think it deserves more potential explanation to that.

Response - Thank you for identifying this. We have added the following text to the discussion section: “Missing data can lead to a loss of statistical power or introduce an unexpected selection bias. However, in this study the number of missing responses to questions in the baseline survey and cohort follow-up visit were generally low, and a comparison of characteristics of those lost to follow-up to those who were followed did not suggest that the two groups were inherently different.”

4. Reviewer 3 comments

Lewis and colleagues studied socio-demographic, behavioural and biological determinants of HIV incidence among adolescent girls and young women (AGYW) in South Africa. They used a proximate determinants framework to define pathways through which HIV infections could occur in this vulnerable group. The authors concluded that retaining AGYW in school, and having their partners access voluntary medical male circumcision, utilize condoms and be on HIV treatment as prevention all reduce risks of their acquisition of HIV. They also concluded that family support reduces AGYW risky sexual behaviour and HIV acquisition. The authors therefore highlighted the importance of designing and implementing community-based HIV combination prevention programs that effectively address the identified structural, biological and behavioural HIV risk factors in their design. The research findings are fully consistent with the existing literature and add value to the body of evidence in regard to the causal pathways of HIV acquisition. The manuscript has a number of strengths. It measures the relationships between both proximate and underlying determinants with HIV incidence and elucidates how underlying determinants influence proximate determinants. It also elucidates causal pathways for the HIV acquisition. Finally, it measures HIV incidence levels in sub-groups of AGYW in this area. One study weakness is that there may be social desirability bias which could have led to underreporting of risky sexual behaviour. The authors however acknowledge this weakness to be taken into account in the interpretation of the study findings. My overall recommendation is that this is a technically sound manuscript that is well written. It should be accepted with very minor revisions.

Response - Thank you for reviewing our manuscript and for your encouraging feedback!

4.1 In the introduction, line 62, you could consider specifying to what extent the risk in this sub-group has declined, and to what extent the risk of HIV remains substantial.

Response –While all referenced manuscripts suggest that incidence is declining, the magnitude of the reported declines differs by methodology and location of research. As such, we have decided not to include this detail. The extent of the risk of HIV for AGYW in this region is summarised in the line “approximately 4,200 AGYW became infected with HIV every week in 2020 [2].”

4.2 In line 65 also in the introduction, you could consider replacing “campaigns” with another word, like “efforts”.

Response- We have changed this to ‘programmes’.

4.3 Line 223-225 in the results section refers to AGYW 15-19 years old who received support. The subsequent sentence (line 225-226) gives the incidence among AGYW who did not receive support. Though the incidence among AGYW who received support in included in Table 1, for easier comparison, it could help to include the incidence among those who received support in the text.

Response - We have added this detail: “Among those that did not receive this support, HIV incidence was 10.40 (95% CI: 5.67-19.09) per 100 person-years compared to 3.17 (95% CI: 2.38-4.21) among those who did.”

4.4 For line 229-231 also in the results section, it may be important to report what proportion of AGYW who reported knowingly having sex with individuals who were HIV positive and not on ART did not use protection.

Response - Only 5(10%) of the 48 reported consistent condom use in the baseline and follow-up questionnaires. We have not added this detail as it could not be added to Table 1 and hence reference to the result may have confused the reader.

Attachment

Submitted filename: Response to Reviewers PONE-D-22-19202.docx

Decision Letter 1

Hamid Sharifi

4 Nov 2022

PONE-D-22-19202R1HIV incidence and associated risk factors in adolescent girls and young women in South Africa: A population-based cohort studyPLOS ONE

Dear Dr. Lewis,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Dec 19 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Hamid Sharifi

Academic Editor

PLOS ONE

Journal Requirements:

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

Reviewer #2: (No Response)

Reviewer #3: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Thank you for answering my questions and adding my suggestions. I congratulate the authors for the manuscript.

Reviewer #2: This is an important Study in a specific population (female adolescents) at high risk of acquiring HIV and their findings could help to design future interventions.

Some comments and editions:

Abstract: In results authors do not describe the overall results, they only describe the risk factors in 2 groups: those 15-19 and 20-24 years. It should be describen first the overall results and then perhaps divided according to range of ages. Additionally, division of ranges of ages, are not pre-specified in the methods sections. Authors, should describe all findings in the group of 15-19 years, and then all the results of population of 20-24 years in order to read it better.

Intro: I could suggest to add something about the fact that adolescent population have proven in clinical trials to be a very challenging population to enroll, adhere and retain in treatment and prevention of HIV... therefore, understand the characteristics of those acquiring HIV would help to design better interventions.

Methods: Here are my main concerns about this study... What if through the multistage sampling (only one household enrolled) you are missing those who are at most risk...? Additionally, only 77% completed. I would analyze the population that completed vs those who did not, in order to show if those are different population. If they are, then results should be interpret with more caution. On the other hand, is there a national registry in which you could compare your incident cases with those registered... It might be that the incidence is different from the reality, just because the sampling could miss those more at risk...?

Additionally, in methods you should pre specify the way you are going to analyze and stratify your population. In results you present different groups: 15-19 years, 20-24 years, then the analysis of those with less education level, also those without sexual history, etc. All groups should be described in methods and the rationale of those divisions.

Results: Comparison with their peers male is presented, not explained in methods how this population was analyzed or picked... It is a very interesting comparison, but it has to be explained in methods in order to see that the comparison is fair and reliable.

Finally, the data were collected from 2014-2017... prevention programs have changed in the last decade. I would like to know why is the data so old and discuss this issue in the discussion section and as a limitation.

Reviewer #3: (No Response)

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

Reviewer #3: Yes: Brian C Chirombo, MBChB, MPH

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2022 Dec 21;17(12):e0279289. doi: 10.1371/journal.pone.0279289.r004

Author response to Decision Letter 1


16 Nov 2022

1. Journal Requirements:

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

We have reviewed all references and updated accordingly.

2. Reviewer 2 comments

This is an important Study in a specific population (female adolescents) at high risk of acquiring HIV and their findings could help to design future interventions.

Some comments and editions:

Abstract: In results authors do not describe the overall results, they only describe the risk factors in 2 groups: those 15-19 and 20-24 years. It should be describen first the overall results and then perhaps divided according to range of ages. Additionally, division of ranges of ages, are not pre-specified in the methods sections. Authors, should describe all findings in the group of 15-19 years, and then all the results of population of 20-24 years in order to read it better.

response: Thank you. We have re-worded the results so that the 15-19-related results appear first followed by those for the 20-24 year-olds. We have added to the methods that separate models were built for the two age groups. In the body of the manuscript, we explain why we took the approach to split the age groups: “Analyses were performed separately for 15-19-year-olds and 20-24-year olds as we hypothesized that the factors affecting young girls who are still of school going age are likely to be different from those affecting women who are out of secondary-school, possibly in tertiary education or seeking employment.” We provide overall incidence results in the abstract, but since separate models were used for measuring the associations for the two age groups, we cannot combine these results to one overall estimate.

Intro: I could suggest to add something about the fact that adolescent population have proven in clinical trials to be a very challenging population to enroll, adhere and retain in treatment and prevention of HIV... therefore, understand the characteristics of those acquiring HIV would help to design better interventions. Methods: Here are my main concerns about this study... What if through the multistage sampling (only one household enrolled) you are missing those who are at most risk...? Additionally, only 77% completed. I would analyze the population that completed vs those who did not, in order to show if those are different population. If they are, then results should be interpret with more caution. On the other hand, is there a national registry in which you could compare your incident cases with those registered... It might be that the incidence is different from the reality, just because the sampling could miss those more at risk...?

response: Thank you for raising this important concern. The survey enrolled one randomly selected person per household (not one household). Our incidence is higher than that reported based on the national estimates for 15-24 year olds (South African National HIV Prevalence, Incidence, Behaviour and Communication Survey, 2017). This is expected given the high HIV prevalence in the region in which the survey was conducted but also provides us with reassurance that our selection – while random – were not unduly biased by refusal rates. The original version of this manuscript was updated with this text in the manuscript: “Compared to those with follow-up data, HIV-negative AGYW who were not available for follow-up (n=808, 23.0%) were more likely to be aged between 20 and 24 (48.2% versus 54.7%) and reside in a rural area (51.7% versus 76.6%). However, the two groups were comparable with respect to education levels, household income, number of lifetime sexual partnerships and STI status at baseline.”

Additionally, in methods you should pre specify the way you are going to analyze and stratify your population. In results you present different groups: 15-19 years, 20-24 years, then the analysis of those with less education level, also those without sexual history, etc. All groups should be described in methods and the rationale of those divisions.

response: The reason for splitting the age groups is provided in the methods: “Analyses were performed separately for 15-19-year-olds and 20-24-year olds as we hypothesized that the factors affecting young girls who are still of school going age are likely to be different from those affecting women who are out of secondary-school, possibly in tertiary education or seeking employment.”

We outline where we exclude those without sexual history and why here in the methods: “Unless otherwise stated, all AGYW, regardless of whether they reported having sex before study enrolment, were included in the analysis. However, models that incorporated sexual behaviour variables that were based on follow-up data excluded, by necessity, AGYW who reported not being sexually active in the 12 months preceding follow-up.”

The analysis of the association between education and other sexual behavioral variables is explained here in the methods: “The association between the underlying determinants and proximate determinants found to be significantly associated with HIV incidence was measured using logistic regression.”

Results: Comparison with their peers male is presented, not explained in methods how this population was analyzed or picked... It is a very interesting comparison, but it has to be explained in methods in order to see that the comparison is fair and reliable.

response: We are uncertain which part of the manuscript this comment relates to. We think this comment relates to an earlier version of the manuscript where an incidence of 0.82 was reported for male peers. This line was removed in the first revision of the manuscript for the reasons the reviewer provides.

Finally, the data were collected from 2014-2017... prevention programs have changed in the last decade. I would like to know why is the data so old and discuss this issue in the discussion section and as a limitation.

response: The efforts of the authors writing the manuscript were redirected to COVID-19 work during 2020 and 2021. We have now highlighted the age of the data in the limitations section. While HIV prevention programmes have changed in the last decade, determinants of risk in young women appear to remain quite consistent – education, family support age-disparate partnerships and high STI prevalence repeatedly present themselves as related factors.

Attachment

Submitted filename: Response to Reviewer.docx

Decision Letter 2

Hamid Sharifi

5 Dec 2022

HIV incidence and associated risk factors in adolescent girls and young women in South Africa: A population-based cohort study

PONE-D-22-19202R2

Dear Dr. Lewis,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Hamid Sharifi

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #2: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #2: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #2: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #2: Authors have nicely addressed all my queries, questions and suggestions. I think this is a very nice manuscript with important data, ready for publication.

Thank you for considering me as reviewer.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #2: Yes: Brenda Crabtree-Ramirez

**********

Acceptance letter

Hamid Sharifi

13 Dec 2022

PONE-D-22-19202R2

HIV incidence and associated risk factors in adolescent girls and young women in South Africa: A population-based cohort study

Dear Dr. Lewis:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Hamid Sharifi

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 File. Sample dataset.

    (PDF)

    Attachment

    Submitted filename: Response to Reviewers PONE-D-22-19202.docx

    Attachment

    Submitted filename: Response to Reviewer.docx

    Data Availability Statement

    All relevant data are within the paper and its Supporting information files.


    Articles from PLOS ONE are provided here courtesy of PLOS

    RESOURCES